CIK: 0001703031 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $1,305,661 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OLMA | OLEMA PHARMACEUTICALS INC | 8,508,641 (+24.3%) | $212,716 (+217.5%) | 16.3% | $11.52 | +54.5% | COM | 68062P106 |
| XFOR | X4 PHARMACEUTICALS INC | 7,967,454 (+227.0%) | $31,870 (+282.4%) | 2.4% | $3.42 | +6.3% | COM NEW | 98420X202 |
| CCCC | C4 THERAPEUTICS INC | 7,171,910 (+545.0%) | $13,698 (+454.9%) | 1.0% | $6.50 | -63.5% | COM STK | 12529R107 |
| XLO | XILIO THERAPEUTICS INC | 7,372,686 (+61.4%) | $4,720 (+22.6%) | 0.4% | $7.01 | -89.3% | COM | 98422T100 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CIDARA THERAPEUTICS INC | 3,020,990 | $289,290 | 22.2% | $47.98 | — | — | 171757206 |
| IPSC | CENTURY THERAPEUTICS INC | 3,538,609 | $1,762 | 0.1% | $3.16 | -80.7% | — | 15673T100 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 7,306,566 (-31.8%) | $256,314 (-15.9%) | 19.6% | $10.88 | +234.4% | ORDINARY SHARES | N62509109 |
| DNTH | DIANTHUS THERAPEUTICS INC | 743,592 (-43.5%) | $30,643 (-40.8%) | 2.3% | $21.73 | +78.4% | COM | 252828108 |
| TNGX | TANGO THERAPEUTICS INC | 653,493 (-75.9%) | $5,790 (-74.6%) | 0.4% | $10.01 | -13.9% | COM | 87583X109 |
| UPB | UPSTREAM BIO INC | 1,329,544 (-45.5%) | $36,097 (-21.3%) | 2.8% | $21.55 | +15.5% | COM | 91678A107 |
| KYTX | KYVERNA THERAPEUTICS INC | 3,110,000 (-7.7%) | $29,234 (+44.6%) | 2.2% | $27.08 | -72.6% | COM | 501976104 |
| PHVS | PHARVARIS N V | 2,802,081 (-11.9%) | $77,758 (-2.0%) | 6.0% | $23.89 | +0.8% | COM | N69605108 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HTFL | HEARTFLOW INC | 12,448,158 | $362,864 | 27.8% | $32.24 | -0.1% | COM | 42238D107 |
| SVRA | SAVARA INC | 17,600,621 | $106,132 | 8.1% | $2.08 | +135.7% | COM | 805111101 |
| ANNX | ANNEXON INC | 5,249,069 | $26,350 | 2.0% | $11.24 | -66.0% | COM | 03589W102 |
| — | MERSANA THERAPEUTICS INC | 346,545 | $10,026 | 0.8% | $7.76 | — | COM | 59045L205 |
| SLDB | SOLID BIOSCIENCES INC | 7,911,669 | $44,622 | 3.4% | $5.76 | -5.9% | COM NEW | 83422E204 |
| RPID | RAPID MICRO BIOSYSTEMS INC | 8,434,560 | $24,460 | 1.9% | $20.66 | -83.2% | CLASS A COM | 75340L104 |
| AVIR | ATEA PHARMACEUTICALS INC | 2,485,638 | $8,874 | 0.7% | $32.23 | -90.1% | COM | 04683R106 |
| CABA | CABALETTA BIO INC | 9,677,125 | $21,193 | 1.6% | $3.63 | -31.8% | COM | 12674W109 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 99,999 | $2,300 | 0.2% | $0.00 | — | *W EXP 99/99/999 | N62509117 |